Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study

被引：1

作者：

Hannawi, Suad ^{[1
]}

Zhang, Rong-Rong ^{[2
]}

Abuquta, Alaa ^{[3
]}

Safeldin, Linda ^{[4
]}

Hassan, Aala ^{[4
]}

Alamadi, Ahmad ^{[4
]}

Hossain, Tasmiah ^{[4
]}

Mostafa, Mohamed ^{[5
]}

Ghoneim, Yasser ^{[5
]}

Solo, Jennifer ^{[5
]}

Zheng, Hong-Xia ^{[6
]}

Wu, Ding-Feng ^{[6
]}

Yu, Dan-Dan ^{[6
]}

Yuan, Jia-Cheng ^{[6
]}

Zhao, Di ^{[6
]}

Lin, Rui ^{[6
]}

Ying, Bo ^{[6
,8
]}

Qin, Cheng-Feng ^{[2
,7
]}

机构：

[1] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Internal Med Dept, Emirates Hlth Serv EHS, Dubai, U Arab Emirates

[2] Acad Mil Med Sci AMMS, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China

[3] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Accid & Emergency Dept, EHS, Dubai, U Arab Emirates

[4] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Gen Surg Dept, EHS, Dubai, U Arab Emirates

[5] PDC FZ LLC, Contract Res Org, Dubai, U Arab Emirates

[6] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou, Peoples R China

[7] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China

[8] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou 215123, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL MEDICINE | 2023年 / 13卷 / 08期

关键词：

D O I：

10.1002/ctm2.1387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[41] Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study
Mei, Heng
Chen, Xiequn
Zhou, Jianfeng
Luo, Jianmin
Shi, Qingzhi
Liu, Jing
Wu, Depei
Chen, Guoan
Tai, Yanfei
Xiong, Junye
Zou, Jianjun
Hu, Yu
ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (02)
[42] A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults
Nagai, Hideaki
Ikematsu, Hideyuki
Tenjinbaru, Kazuyoshi
Maeda, Atsushi
Drame, Mamadou
Roman, Francois P.
BMC INFECTIOUS DISEASES, 2010, 10
[43] A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults
Hideaki Nagai
Hideyuki Ikematsu
Kazuyoshi Tenjinbaru
Atsushi Maeda
Mamadou Dramé
François P Roman
BMC Infectious Diseases, 10
[44] An open-label, comparative, single dose, clinical Phase I study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults
Choi, Seuk Keun
Baik, Yeong Ok
Kim, Chan Wha
Kim, Soo Kyung
Oh, Il Nam
Yoon, Hyeseon
Yu, Dajung
Lee, Chankyu
VACCINE, 2021, 39 (19) : 2620 - 2627
[45] Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
Calabro, Luana
Morra, Aldo
Fonsatti, Ester
Cutaia, Omella
Fazio, Carolina
Annesi, Diego
Lenoci, Marica
Amato, Giovanni
Danielli, Riccardo
Altomonte, Maresa
Giannarelli, Diana
Di Giacomo, Anna Maria
Maio, Michele
LANCET RESPIRATORY MEDICINE, 2015, 3 (04): : 301 - 309
[46] A multicenter, open-label, single-arm phase 1/2 study to evaluate the safety and efficacy of FCN-159 in pediatric participants with neurofibromatosis type 1
Hu, Xiaojie
Wang, Jinhu
Li, Wenbin
Zeng, Kang
Li, Yanling
Tao, Juan
Guan, Zhonghai
Kang, Zhuang
Xu, Zhongyuan
Li, Changxing
Ma, Yaohui
Yang, Liu
Wu, Zhuli
Han, Pu
Lin, Hongmei
Li, Ben
Hui, Ai-Min
Wang, Xingli
Lin, Xiaoxi
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[47] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
Yoko Edahiro
Kohshi Ohishi
Akihiko Gotoh
Katsuto Takenaka
Hirohiko Shibayama
Takayuki Shimizu
Kensuke Usuki
Kazuya Shimoda
Masafumi Ito
Scott A. VanWart
Oleh Zagrijtschuk
Albert Qin
Hiroaki Kawase
Narihisa Miyachi
Toshiaki Sato
Norio Komatsu
Keita Kirito
International Journal of Hematology, 2022, 116 : 215 - 227
[48] Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine
Fujikawa, Priscilla
Shah, Farhan A.
Braford, Michalla
Patel, Kashyap
Madey, Jason
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
[49] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
Edahiro, Yoko
Ohishi, Kohshi
Gotoh, Akihiko
Takenaka, Katsuto
Shibayama, Hirohiko
Shimizu, Takayuki
Usuki, Kensuke
Shimoda, Kazuya
Ito, Masafumi
VanWart, Scott A.
Zagrijtschuk, Oleh
Qin, Albert
Kawase, Hiroaki
Miyachi, Narihisa
Sato, Toshiaki
Komatsu, Norio
Kirito, Keita
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (02) : 215 - 227
[50] The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses
Bieniasz, Paul D.
CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : 1321 - 1323

← 1 2 3 4 5 →